Safe use of proton pump inhibitors in patients with cirrhosis

AIMS: Proton pump inhibitors (PPIs) belong to the most frequently used drugs, also in patients with cirrhosis. PPIs are extensively metabolized by the liver, but practice guidance on prescribing in cirrhosis is lacking. We aim to develop practical guidance on the safe use of PPIs in patients with ci...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Br J Clin Pharmacol
Autors principals: Weersink, Rianne A., Bouma, Margriet, Burger, David M., Drenth, Joost P.H., Harkes‐Idzinga, S. Froukje, Hunfeld, Nicole G.M., Metselaar, Herold J., Monster‐Simons, Margje H., van Putten, Sandra A.W., Taxis, Katja, Borgsteede, Sander D.
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2018
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6046475/
https://ncbi.nlm.nih.gov/pubmed/29688583
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.13615
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars